Antiviral TX Strategy

Follow-Up Lab Monitoring

1. Hgb, Hct, and WBC with differential and platelet count, creatinine
• At week 1 or 2, at week 4, then every 1-2 months
2. Serum ALT
• At month 1, then every 1-2 months
3. Pregnancy test
• Monthly during therapy and for 6 months after completing therapy
4. TSH
• At least every 12 weeks during therapy
5. Blood glucose
• At least every 12 weeks during therapy
6. HCV RNA by quantitative and/or qualitative assay
• At week 4, 12, and 24 during therapy, at end of therapy, and 6 months after completion of therapy

Next: Rules for Adjusting Therapy for CBC Changes